Literature DB >> 3933379

Purification of peroxisomes from livers of normal and clofibrate-treated mice.

D I Crane, A C Hemsley, C J Masters.   

Abstract

A method for the isolation of peroxisomes from livers of normal and clofibrate-treated mice is described. The method utilizes glutaraldehyde to stabilize peroxisomal membranes, and isopycnic centrifugation of a light mitochondrial fraction through a linear metrizamide gradient to achieve optimal resolution from other organelles. On the basis of the biochemical and morphological data, the peroxisomal preparations are indicated as of high purity: contamination by mitochondria, lysosomes, and plasma membranes is negligible, and the level of contaminating microsomes is around 5% for normal peroxisomes and 8% for peroxisomes from clofibrate-treated mice. Peroxisomal membranes prepared by carbonate extraction contain two major polypeptides of approximately 70,000 Da, and show 2 and 8% contamination by microsomal membrane protein for the preparations from normal and clofibrate-treated mice, respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933379     DOI: 10.1016/0003-2697(85)90250-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Association of glyoxylate and beta-oxidation enzymes with peroxisomes of Saccharomyces cerevisiae.

Authors:  M T McCammon; M Veenhuis; S B Trapp; J M Goodman
Journal:  J Bacteriol       Date:  1990-10       Impact factor: 3.490

2.  Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators.

Authors:  N Chen; D I Crane
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  On the compartmentalization of catalase, fatty acyl-CoA oxidase and urate oxidase in mammalian livers, and the influence of clofibrate treatment on this microlocalization.

Authors:  A Hemsley; M Pegg; D Crane; C Masters
Journal:  Mol Cell Biochem       Date:  1988-10       Impact factor: 3.396

4.  Alterations in the integrity of peroxisomal membranes in livers of mice treated with peroxisome proliferators.

Authors:  D I Crane; J Zamattia; C J Masters
Journal:  Mol Cell Biochem       Date:  1990-08-10       Impact factor: 3.396

5.  On the interactions of catalase with subcellular structure.

Authors:  M Pegg; D Crane; C Masters
Journal:  Mol Cell Biochem       Date:  1989-03-16       Impact factor: 3.396

6.  Changes to the integral membrane protein composition of mouse liver peroxisomes in response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate.

Authors:  D I Crane; N Chen; C Masters
Journal:  Mol Cell Biochem       Date:  1988-05       Impact factor: 3.396

7.  Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype.

Authors:  Megan Maxwell; Jonas Bjorkman; Tam Nguyen; Peter Sharp; John Finnie; Carol Paterson; Ian Tonks; Barbara C Paton; Graham F Kay; Denis I Crane
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata.

Authors:  J L Hughes; A Poulos; D I Crane; C W Chow; L J Sheffield; D Sillence
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.